Rights granted for reproduction by any legitimate news organization (or blog, or syndicator). However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
Story Reads as of 2021-06-20 14:48:02: 3,243 views
REFERENCES: Biotechnology News, Epeius Biotechnologies Corporation, Clinical Trial For Pancreatic Cancer, Rexin-G, Mayo Clinic, Tumor-Targeted Gene Therapy Vector, rexin g, human cyclin G1 gene, cancer cell growth, Targeted Gene Delivery System, TDS, Cyclin G1, NIH/Recombinant Advisory Committee, Institutional Review Board of Mayo Clinic, Los Angeles, California, Orphan Drug designation, FDA, Mayo Clinic Cancer Center Epeius Biotechnologies Corporation | ID:4915